Last week saw the newest half-yearly earnings release from Shanghai Forest Cabin Cosmetics Group Co., Ltd. (HKG:2657), an important milestone in the company's journey to build a stronger business. Results overall were respectable, with statutory earnings of CN¥2.87 per share roughly in line with what the analysts had forecast. Revenues of CN¥1.5b came in 2.5% ahead of analyst predictions. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Shanghai Forest Cabin Cosmetics Group after the latest results.
Taking into account the latest results, the most recent consensus for Shanghai Forest Cabin Cosmetics Group from seven analysts is for revenues of CN¥3.41b in 2026. If met, it would imply a notable 18% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to shoot up 34% to CN¥4.10. Before this earnings report, the analysts had been forecasting revenues of CN¥3.41b and earnings per share (EPS) of CN¥4.10 in 2026. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.
See our latest analysis for Shanghai Forest Cabin Cosmetics Group
It will come as no surprise then, to learn that the consensus price target is largely unchanged at HK$100. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. There are some variant perceptions on Shanghai Forest Cabin Cosmetics Group, with the most bullish analyst valuing it at HK$131 and the most bearish at HK$74.14 per share. Note the wide gap in analyst price targets? This implies to us that there is a fairly broad range of possible scenarios for the underlying business.
One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. We would highlight that Shanghai Forest Cabin Cosmetics Group's revenue growth is expected to slow, with the forecast 38% annualised growth rate until the end of 2026 being well below the historical 67% growth over the last year. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 14% annually. Even after the forecast slowdown in growth, it seems obvious that Shanghai Forest Cabin Cosmetics Group is also expected to grow faster than the wider industry.
The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.
With that in mind, we wouldn't be too quick to come to a conclusion on Shanghai Forest Cabin Cosmetics Group. Long-term earnings power is much more important than next year's profits. At Simply Wall St, we have a full range of analyst estimates for Shanghai Forest Cabin Cosmetics Group going out to 2028, and you can see them free on our platform here..
We also provide an overview of the Shanghai Forest Cabin Cosmetics Group Board and CEO remuneration and length of tenure at the company, and whether insiders have been buying the stock, here.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.